Elizabeth Trehu, Chief Medical Officer at Jounce Therapeutics, Inc. (JNCE), sold 9,285 shares at $1.12 ($10K) on 2023-01-10, disclosed to the SEC on 2023-01-11.
Seasonal sale ($10k) by Chief Medical Officer — this insider has traded JNCE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.10 | 4,159 | $5K | 44.3% |
| 2 | $1.12 | 5,126 | $6K | 55.7% |
| Total | $1.11 avg | 9,285 | $10K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-22 | $78K | — | Filing → |
| JNCE | SELL | 2021-01-11 | $36K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |